HeartBeam, Inc. (BEAT)

Market Cap	53.36M -12.1%
Revenue (ttm)	n/a
Net Income	-20.62M
EPS	-0.66
Shares Out	40.12M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	459,135
Open	1.235
Previous Close	1.220
Day's Range	1.220 - 1.370
52-Week Range	0.540 - 4.000
Beta	-0.81
Analysts	Strong Buy
Price Target	6.75 (+407.52%)
Earnings Date	Mar 12, 2026

About BEAT

HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Nov 11, 2021
• Employees: 16
• Stock Exchange: NASDAQ
• Ticker Symbol: BEAT
• Website: https://www.heartbeam.com

Analyst Summary

According to 2 analysts, the average rating for BEAT stock is "Strong Buy." The 12-month stock price target is $6.75, which is an increase of 407.52% from the latest price.

Price Target

$6.75

(407.52% upside)

Analyst Consensus: Strong Buy